EFMH
PTCT icon

E Fund Management (HK)’s PTC Therapeutics PTCT Stock Holding History

E Fund Management (HK)’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.2K Buy
309
+80
+35% +$5.78K 0.01% 266
2026
Q1 		$15.6K Buy
+229
New +$16.2K 0.01% 240

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

E Fund Management (HK)'s PTCT Position: Q2 2026 in Review

E Fund Management (HK) increased its PTC Therapeutics (PTCT) stake by 35% in Q2 2026, buying an estimated $5.78K and bringing the position to 309 shares worth $25.2K. The position accounts for 0.01% of the portfolio, ranked #266.

E Fund Management (HK) first reported a position in PTCT in Q1 2026 and has held it in 2 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • E Fund Management (HK) held 309 shares of PTC Therapeutics worth $25.2K as of Q2 2026.
  • E Fund Management (HK) bought 80 PTC Therapeutics shares in Q2 2026, an estimated $5.78K.
  • PTC Therapeutics made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #266 holding.
  • E Fund Management (HK) first reported a position in PTC Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.